Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study

Karine Briot, Michèle Tubiana-Hulin, Laurent Bastit, Ioana Kloos, Christian Roux

Open source

DOI
10.1007/s10549-009-0692-7
Published
2009-12-25
Container
Breast Cancer Research and Treatment
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10549-009-0692-7,
  title = {Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study},
  author = {Karine Briot and Michèle Tubiana-Hulin and Laurent Bastit and Ioana Kloos and Christian Roux},
  year = {2009},
  journal = {Breast Cancer Research and Treatment},
  doi = {10.1007/s10549-009-0692-7},
  url = {https://doi.org/10.1007/s10549-009-0692-7}
}

RIS

TY  - JOUR
TI  - Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study
AU  - Karine Briot
AU  - Michèle Tubiana-Hulin
AU  - Laurent Bastit
AU  - Ioana Kloos
AU  - Christian Roux
PY  - 2009
JO  - Breast Cancer Research and Treatment
DO  - 10.1007/s10549-009-0692-7
UR  - https://doi.org/10.1007/s10549-009-0692-7
ER  - 

APA

Briot, K., Tubiana-Hulin, M., Bastit, L., Kloos, I., & Roux, C. (2009). Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-009-0692-7

Source records